baber/WOPTO huggingface dataset:
Patent JP-2000507927-A (JP)
Title: 試料からの自動核酸抽出
IPC: C07H21/00
Filed: 1997-03-05
Abstract: (57)【要約】
洗浄流体が閉じられた容器から汲み上げられ、容器中に入れられた空気がろ過される閉鎖試料処理システム。固相を乾燥させるためなど、試料処理システム中に送り込まれた空気がろ過される。洗浄流体容器または空気ドライヤからの管は、核酸試料（例えばエーロゾル）が管中に流れ込まないように流体を一方向にのみ流す。核酸に接触する（したがって潜在的に汚染の発生源の働きをする）試料処理システムの部分は使い捨てデバイスおよび廃棄物管である。しかしながら、使い捨てデバイスは試料プロセッサから完全に取り外せ、使用後に処分でき、廃棄物管は流体を一方向のみに流して廃棄物とし、したがって核酸汚染の発生源の働きをしない。
Patent JP-2000506756-A (JP)
Title: 特に視覚障害者のための案内装置
IPC: E01F9/04
Filed: 1997-03-10
Abstract: (57)【要約】
本発明の案内装置は、各々が磁場を生成する間隔をおいた２つの永久磁化領域を含む。この２つの永久磁化領域を、永久磁化領域よりも強度の低い磁場を生成する別の領域の両側に設けることもでき、一実施例ではこの磁場強度の低い領域は磁場を全く生成しない。本装置は、永久磁化領域が生成した磁場を検出するための携帯手段を含んでもよく、センサは人が使用する杖に装着されてもよい。別の実施例において、永久磁化領域は、互いにまたは強度の低い磁場を生成する領域と対比するか、または異なる表面特性を有するか、あるいはその両方である。
Patent JP-2000507974-A (JP)
IPC: A61K39/385
Filed: 1998-01-21
Abstract: The invention relates to a polysaccharide-peptide conjugate wherein the polysaccharide is advantageously immunogenic, which comprises a polysaccharide chain composed of repeat units and a plurality of peptide moieties, each moiety containing a cysteine residue and being covalently attached at random along the polysaccharide chain, through an indirect bond being achieved through either a linker or a spacer-linker moiety provided that the spacer entity of the spacer-linker moiety is linked to the amino, hydroxyl or carboxyl group of the polysaccharide. To this end a useful linker may be, e.g., N-(gamma-maleimidobutyrloxy)succinimide ester. Such a conjugate may typically exhibit a "Rake" configuration. Conjugation processes are also disclosed. Conjugates of the invention are in particular useful in the vaccinal field to elicit a protective long term immune response against a pathogenic microorganism from which the Immunogenic polysaccharide is derived.
Patent JP-2002514980-A (JP)
IPC: B31B19/98
Filed: 1996-05-13
Abstract: Apparatus for automatically removing bags from a supply conveyor and stacking a predetermined number of bags upon raised pins. The stacks are then placed on a stack transfer assembly that is then moved into a transfer station wherein the stacks are placed on wickets. An endless accumulator conveyor is arranged to deliver the wickets into the transfer station in timed relation with the movement of the transfer assembly between stations.
Patent JP-2000508577-A (JP)
IPC: B05C17/02
Filed: 1997-04-10
Abstract: A paint roller consisting of a one-piece handle made of plastic provided with a handgrip and of a paint roll which can be mounted rotatably on the front end of the handle, in which the handle comprises over at least part of its length transversely running reinforcement elements which are interconnected in a reinforcing manner by longitudinal bracing.
Patent JP-H11509068-A (JP)
Title: データフェッチサービスのための方法および制御メカニズム
IPC: H04N1/327
Filed: 1997-04-17
Abstract: (57)【要約】
特に、通信ネットワーク（Ｎ）内の送信側（Ｓ）が大量のデータをフェッチして、通信ネットワーク（Ｎ）内で送信しなければならない場合に、フェッチサービスの制御装置（ＣＭ）がデータをフェッチする時点を判定する。
Patent JP-2002515847-A (JP)
Title: 単層カーボンナノチューブ類から形成された炭素繊維類
IPC: G01Q60/16
Filed: 1998-03-06
Abstract: (57)【要約】
単層カーボンナノチューブおよび無定形炭素汚染物質を含む混合物の精製法が開示される。該方法は、無定形炭素を除くのに十分な酸化条件下で該混合物を加熱した後、少なくとも約８０重量％の単層カーボンナノチューブを含む生成物を回収する工程を包含する。長さが約５ないし５００ｎｍの管状炭素分子の製造法も開示される。該方法は、単層ナノチューブ含有材料を切断して長さが５−５００ｎｍの範囲の管状炭素分子混合物を作り、そして実質的に等しい長さの分子の一部を単離する工程を包含する。このナノチューブは、単数又は複数で送電ケーブル、太陽電池、電池に、アンテナ、モレキュラーエレクトロニクス、プローブおよびマニプレーターとして、ならびに複合材料に用いることができる。
Patent JP-2000509994-A (JP)
IPC: A61P7/04
Filed: 1997-05-13
Abstract: A process is presented for reducing the detrimental influence of certain proteases on recombinant human protein and polypeptide production in a cell culture, which comprises adding an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium. The cell culture medium for cultivating cells expressing and secreting a biologically active recombinant human polypeptide contains an inhibitor of metal-dependent proteases or chymotrypsins, or a combination thereof. Recombinant factor VIII which has been produced in a cell culture medium according to the present process is useful for the manufacture of a medicament for administration to a patient having the symptoms of hemophilia A and for treatment of hemophilia A by administration of a therapeutically effective amount of recombinant factor VIII.
Patent JP-2001518864-A (JP)
IPC: B65G47/64
Filed: 1998-04-08
Abstract: A route switching apparatus for conveying articles, including a plurality of lines suitable for conveying the articles along respective separate paths and a body having a polygonal cross-section and pivotable about a longitudinal axis. The body is positioned along the plurality of lines between an entry and an exit of the lines. The body has a plurality of lateral faces with transfer lines formed on respective lateral faces. The transfer lines communicate with respective lines of the plurality of lines between the entry and the exit. The body is pivotable such that the transfer lines can communicate with different respective lines so that the articles moving along one of the separate paths can transfer to another of the separate paths.
Patent JP-2001519854-A (JP)
Title: 製鋼作業における鉄含有スラッジのリサイクル方法
IPC: C22B7/02
Filed: 1998-01-22
Abstract: (57)【要約】
本発明は、湿式ＢＯＦスクラバ・スラッジをリサイクルの流れの中で取り扱う時に、改良された流量を有する製鋼リサイクル材を作るため湿性スラッジを脱水するためのプロセスに関する。湿性スラッジをＢＯＦスラグに合わしてスラグ／スラッジ混合物を作る。湿性スラッジはこの混合物が１０重量％より大きい水分含有量を持つ原因となり、溶融液体状態より低い温度を有する熱スラグは混合物内の水分を蒸発させ、水分含有量を約４重量％以下に減少する。脱水混合物は製鋼リサイクル材としてリサイクルされる時の流量特性を改善する。
Patent JP-2000511422-A (JP)
Title: シュウ酸を検出するための物質および方法
IPC: C12Q1/26
Filed: 1997-05-30
Abstract: (57)【要約】
本発明は、試料中のシュウ酸を検出するための新規なアッセイ装置に関する。該アッセイ装置は、固体担体マトリックス上に固定化された酵素組成物および色素組成物を含む。本発明は、試料中のシュウ酸の濃度を測定するために使用することもできる。本発明は、さらに、新規なシュウ酸オキシダーゼ組成物および本酵素組成物を調製する方法に関する。シュウ酸オキシダーゼ組成物は、本発明のアッセイ装置において使用することができる。
Patent JP-2000512071-A (JP)
Title: 電球の口金接合剤
IPC: H01J5/58
Filed: 1998-03-26
Abstract: (57)【要約】
本発明はできるだけ樹脂成分の少ない電球用口金接合剤に関する。本発明による口金接合剤は天然樹脂も合成樹脂も含んでおり、その際合成樹脂の成分量は最大で１１重量％であり、天然樹脂成分は最大で５重量％である。充填材としては専ら方解石を使用する。天然樹脂の合成樹脂に対する重量比は０．１〜０．５であると有利である。
Patent JP-2002513317-A (JP)
IPC: A47J37/04
Filed: 1998-05-19
Abstract: The invention relates to a mobile grill, more particularly a horizontal grill. The grill is fed by a power supply, preferably a liquid gas tank, situated on the rear side of the grill. In order to prevent injuries to the operator or persons in his or her surrounding area, safety devices are provided which cut off the gas supply in an case of emergency. The grill can be handled and carried by a single person.
Patent JP-2001525714-A (JP)
IPC: A61M15/00
Filed: 1998-05-22
Abstract: A dosing device comprising a dispensing means for dispensing a dose material, and a dose actuation mechanism, in which the dose actuation mechanism comprises a readily deflectable member, and a cascade of at least two pivoted elements, movement of one causing movement of the other, wherein the deflectable member is moveable by the user, and its movement is transferred to the first of the cascade of pivoted elements, so as to actuate the dispensing means. A first biasing means communicates with one pivoted element so that as movement is transferred between the pivoted elements, energy stored in the first biasing means is released to increase the force associated with the movement. A dose actuating mechanism for use in a dosing inhaler is also provided.
Patent MX-143836-A (MX)
Inventor: MAQUELIN CHARLES
IPC: G04D3/00
Filed: 1976-06-29
Abstract: The watchcase element is made from molybdenum, by machining, in order to give it the final shape, dimensions and surface finish. Carburation of the element is then carried out by heat treatment in a pure ethylene atmosphere, under a pressure of the order of 10<-2> torr, at a temperature of between 1250 and 1450 DEG C. This treatment is continued for approximately 2 h. An extra-hard carburised layer is thus produced at the surface of the component, without modifying its dimensions and surface finish.
Patent MX-161578-A (MX)
Inventor: JACKSON MICHAEL AVERY
IPC: B01F7/16
Filed: 1985-02-11
Abstract: A froth flotation machine (40) having a rotary air-supply shaft (42) vertically disposed in a vessel (41) includes an impeller (50) comprising a series of interconnected blades (52,53). Extending radially and fixedly depending from a flat impeller plate (52) is a pumping blade extending over one-half the distance from the plate outer periphery to the shaft. Blade (53) is an air-inducing vane of lesser radial length which aids in inducing air from shaft (42) to pumping blades (52). The vane has a height less than 50% of the height of the pumping blade. The pumping blade has an L/H ratio of from 0.8 to 1.4 where L is its radial length and H is its vertical height. Slurry is pumped by the blades (52) from bottom of the vessel through a central aperture in a surrounding fixed stator base (56) having stator bars (55) extending upwardly and forming parallel-sided passageways (63,64) for pumped fluid.
Patent NZ-209588-A (NZ)
Title: Production of human immune interferon and pharmaceutical composition
Inventor: SUSUMU HONDA
IPC: C07K16/00
Filed: 1984-09-18
Abstract: An intact human immune interferon protein and a method for its extraction and purification is disclosed. This method permits the purification to homogeneity of intact recombinant human immune interferon using extraction of transformed microorganisms containing the interferon with a protease inhibitor, such as guanidine-HCl, and purification with monoclonal antibodies to immune interferon.
Patent NZ-226224-A (NZ)
Title: Preparation of perindopril t-butyl amine salt, and intermediates thereof
Inventor: VINCENT MICHEL
IPC: A61K38/00
Filed: 1988-09-16
Abstract: Process for the industrial synthesis of perindopril, in which (2S,3aS,7aS)-2-carboxyperhydroindole is condensed with N-[(S)-1-carbethoxybutyl]-(S)-alanine after protection of the carboxyl group, the product resulting from the condensation being then subjected to deprotection of the carboxyl carried by the heterocyclic ring. The (2S,3aS,7aS)-2-carboxyperhydroindole and N-[(S)-1-carbethoxybutyl]-(S)-alanine are themselves obtained in excellent conditions from 2-carboxyindole and from L-alanine respectively, both available on an industrial scale.
Patent NZ-227380-A (NZ)
Title: Producing blocks of self-adhesive labels and applying the labels to a body
Inventor: LACY ROBERT MICHAEL
IPC: B31D1/02
Filed: 1988-12-19
Abstract: A method of producing blocks of self-adhesive labels or the like comprises feeding continuously to a cutting device (12, 13; 33, 34) a continuous label stock (10; 30) which on one face has a number of repeated images (11; 31) overlaid by a release coating and on the other face has a pressure-sensitive adhesive coating (16; 32). In the cutting device a succession of sheets (20, 37), each having more than one image, is cut from the stock and the sheets are formed into a stack (21; 38) of superimposed cut sheets, either simultaneously with the cutting or in a subsequent step. Finally, a number of blocks of superimposed labels or the like, each having a single image, are cut from the stack of sheets. Various methods of applying the labels from the blocks to cylindrical or non-cylindrical bodies are given.
Patent NZ-228110-A (NZ)
Title: Transverse ribbed conduit connection
Inventor: FARRELL GRANT D
IPC: H02G3/06
Filed: 1989-02-23
Abstract: A connection device (12) for use insecuring an end of a corrugated pipe (16) to a fitting (14) such as a terminal box connector or a pipe-to-pipe coupling has an array of fingers (20) extending axially from an annular ring (18), for insertion into the fitting. Enlarged head portions (22) at the inner ends of the fingers (20) serve to engage the ribs or corrugations on the pipe outer surface, when a pipe (16) is inserted therepast, and also provide a differentiated camming action to secure engagement of the head portions (22) with a corrugation of the pipe (16) and to preventt withdrawal of the pipe from the fitting (14). The fitting (14) with which the device is combined also has an axially extended inner peripheral seat against which the pipe corrugations seat, to preclude passage of concrete between the pipe (16) and the fitting (14).
Patent NZ-228809-A (NZ)
Title: Compression of run length and colour encoded video data: picture content changes only encoded
Inventor: MUSIC JOHN
IPC: H04N11/04
Filed: 1989-04-19
Abstract: The method and system of compressing and decompressing digital color video data in a video communication system utilizes a digital color video signal having three video color components, and involves the determination of a predetermined number of the most visually significant combinations of color components in a picture frame, and the encoding of the color components as compressed color codes in a series of run length and compressed color code combinations. Line-to-line differences and movement of edges and segments of the picture frames are determined, and frame-to-frame differences are also encoded to reduce the amount of information to a minimum. Further statistical encoding of at least a portion of the run length and color code combinations is also provided. The digitally compressed color component codes are decoded according to a look up table to form a table of the three digital color components for each run length, and the run lengths and corresponding color components are stored in an array in a buffer memory to represent the scan lines in a video picture frame.
Patent NZ-240469-A (NZ)
Title: Use of an aqueous dispersion of bentonite and an electrolyte (which prevents swelling of the bentonite) in making paper
Inventor: CLUYSE JEAN
IPC: D21H17/67
Filed: 1991-11-04
Abstract: Bentonite swelling clay is provided to a paper making mill as a fluid concentrate containing more than 15% bentonite wherein swelling of the bentonite is prevented by inorganicelectrolyte in the concentrate, and the bentonite swells upon dilution either before addition of the cellulosic suspension or after addition.
Patent NZ-244155-A (NZ)
Title: Hybrid cytokine with parts from at least 2 of leukaemia inhibitory factor (lif), granulocyte-colony stimulating factor (g-csf), interleukin-6 and oncostatin-m
Inventor: TODARO GEORGE JOSEPH
IPC: C07K16/00
Filed: 1992-08-31
Abstract: Hybrid cytokines containing four helical regions, each of which is derived from a corresponding alpha-helical region in leukemia inhibitory factor (LIF), granulocyte colony stimulating factor (G-CSF), interleukin-6 (IL-6) or oncostatin-M (OSM) are disclosed. These hybrid cytokines may further contain linking regions also derived from corresponding linking regions in these factors. The hybrid cytokines offer a unique spectrum of activities useful in treating conditions for which the native cytokines are useful or in treating conditions characterized by an excess of the native cytokines.
Patent NZ-255815-A (NZ)
Title: Particle binders for high bulk fibres for absorbent articles
Inventor: HANSEN MICHAEL R
IPC: D04H1/64
Filed: 1993-08-16
Abstract: This invention concerns polymeric and non-polymeric binders for fibers and the use of such binders in binding particles to fibers.
Patent NZ-259595-A (NZ)
Title: Producing mechanical or chemi-mechanical pulp: two step process, with first step below softening point of lignin
Inventor: HOEGLUND HANS
IPC: D21C9/10
Filed: 1993-12-08
Abstract: A method of producing mechanical and chemi-mechanical pulp with a yield above 85 % from lignocellulose-containing material for the manufacture of paper or board products. The material is subjected to mechanical processing in at least two steps. The material at its feed into the first step has a temperature below the softening temperature of lignin. When the material is fed into at least one subsequent processing step, it shall have a temperature above the softening temperature of lignin.
Patent NZ-262237-A (NZ)
Title: Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in
Inventor: QUAY STEVEN CARL
IPC: A61K49/22
Filed: 1994-01-19
Abstract: Agents for enhancing the contrast in a diagnostic ultrasound procedure comprise colloidal dispersions of the liquid-in-liquid type, i.e., emulsions or microemulsions, in which the dispersed liquid phase is a liquid having a boiling point below the temperature of the animal to be imaged and which therefore undergoes a phase change from a dispersed liquid to a highly echogenic dispersed gaseous foam or kugelschaum following administration to the animal. The liquid state of the dispersed phase allows one to manufacture extremely stable, pharmaceutically acceptable emulsions with particle sizes typically below 1000 nm. The gaseous state at body temperature yields highly echogenic microbubbles, typically below 10,000 nm in diameter, which are effective as ultrasound contrast agents. Intravenous, intraarterial, oral, intraperitoneal, and intrauterine dosage forms, methods of administration, and imaging techniques are described.
Patent NZ-270574-A (NZ)
Title: Priming seeds for faster germination and longer shelf life by subjecting to water stress and heat treatment
Inventor: SCHIPPER JOB
IPC: A23B9/00
Filed: 1995-02-27
Abstract: A method of treating primed seeds which results in a prolongation of shelf life compared to optionally dried conventionally primed seeds of the same species having substantially the same moisture content (MC), wherein the primed seeds are subjected to a water stress, a heat treatment or a combination thereof and are subsequently-where desired- dried back to a desired MC and seeds obtainable by such a method.
Patent NZ-276858-A (NZ)
Title: Glass fibre insulation product; irregularly shaped glass fibres of two different glasses with different coefficients of thermal expansion
Inventor: HOUPT RONALD A
IPC: D04H1/72
Filed: 1994-10-28
Abstract: A glass fiber insulation product comprises irregularly-shaped glass fibers of two different glasses having differing coefficients of thermal expansion, with the irregularly-shaped dual-glass fibers exhibiting a substantially uniform volume filling nature, and providing improved recovery and thermal conductivity abilities even in the absence of a binder material.
Patent NZ-307178-A (NZ)
Title: Medicament for contraception; contains two, separately packed, sequential hormonal components
Inventor: SPONA JURGEN
IPC: A61K31/585
Filed: 1996-04-04
Abstract: combined pharmaceutical preparation with two sequential administration hormonal components that are separately packed in a packaging unit. Each hormonal component consists of a plurality of separately packed daily dosage units that may be individually withdrawn from the package. A first hormonal component contains as hormonal active substance a combination of an oestrogen preparation eg 17b-estradiol, ethinylestradiol and  17b-estradiol valerate, and of a gestagen preparation eg gestodene, levonorgestrel and desogestrel, in a dose that is at least sufficient to inhibit ovulation. The second hormonal component contains as hormonal active substance only an oestrogen preparation. The first hormonal component comprises 23 or 24 daily units and the second hormonal component comprises 4, 3, or 2 daily units. Between both hormonal components are placed 2 or 1 active substance-free daily units (placebos) or are indicated 2 or 1 pill-free days. The total number of hormonal daily units and active substance-free daily units or pill-free days equals the total number of days in the desired cycle that has however at least 28 days. This combined preparation for feminine contraception has an as low as possible oestrogen content in each individual dosing unit and also a low total hormone content per administration cycle, while having a high contraceptive safety, a low incidence of follicle development, and allows an irreproachable cycle control and reliable avoidance of spotting and other undesirable side effects.
Patent NZ-314598-A (NZ)
Title: Set top terminal for cable tv system for use with menu selection of programs
Inventor: HENDRICKS JOHN S
IPC: G06F17/00
Filed: 1993-12-02
Abstract: A novel advanced set top terminal capable of digital decompression, menu generation, interactivity and other advanced functional capabilities for use in a television program delivery system (200) is described. The invention relates to methods and apparatus for upgrading existing set top terminals (220) to provide menu generation capability and advanced functional capabilities. The invention is particularly useful in television program delivery systems (200) with hundreds of channels of programming, providing (i) menu driven program selection through the addition of an upgrade module (300) or menu generation card and (ii) advanced functional capabilities using a set of hardware upgrades (e.g., 130) and/or an expansion card. Specifically, the invention is an upgradeable system that supports advanced set top functionality through the use of internal software, hardware upgrades, an upgrade module and/or expansion cards. The upgraded hardware generally includes a microprocessor, various input/output ports (e.g., 308), processing circuitry (e.g., 108) and memory (e.g., 116). The invention results in an upgraded set top terminal that supports: menu generation; picture-on-picture displays; program catalogue services; interactive services; telephone caller identification; digital audio reception; VCR control; HDTV reception; and backyard satellite system interoperability, among other features and capabilities.
Patent NZ-334713-A (NZ)
Title: Methods for in vitro determination of erythropoietin bioactivity
Inventor: LISI PETER J
IPC: G01N33/74
Filed: 1996-09-20
Abstract: An in vitro method of determining in vivo EPO activity. The method comprises treating a portion of a sample containing EPO under conditions that remove desialylated EPO, and measuring the in vitro EPO activity of the treated portion of the sample compared to that of the untreated portion. Desialylated EPO is removed from the treated portion of the sample by incubation with cells of the human hepatoma cell line HepG2, and in vitro EPO activity is determined by incubating the treated portion of the sample with cells of an EPO-responsive cell line and measuring the proliferation or viability of the EPO-responsive cells.